Gleevec

Product NDC
0078-0401
11-digit product format
000780401
Labeler code
0078
Product ID
0078-0401_cbc7561e-5e16-4e05-9c07-52626c43eafc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
imatinib mesylate
Dosage form
TABLET
Route
ORAL
Labeler
Novartis Pharmaceuticals Corporation
Application
NDA021588
Marketing category
NDA
Marketing start
2001-05-15
Substance
IMATINIB MESYLATE
Active strength
100 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Gleevec
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IMATINIB MESYLATE100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii8A1O1M485B
Rxcui403878, 403879, 404588, 404589

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2d2ca280-d5c0-49b4-9bbd-0191c7e031beProduct name120250724
a07e1ba8-e0e6-1fcb-b05d-47e31d308a05Product name920230314

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0078-0401-34Gleevec90 in 1 BOTTLETABLET9040

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0078-0401GLEEVEC (IMATINIB MESYLATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION]35Current NDC, Legacy NDC, 1 package rows20240724_211ef2da-2868-4a77-8055-1cb2cd78e24b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
404588Gleevec 100 MG Oral TabletPSN211ef2da-2868-4a77-8055-1cb2cd78e24b40
404589Gleevec 400 MG Oral TabletPSN211ef2da-2868-4a77-8055-1cb2cd78e24b40
403878imatinib mesylate 100 MG Oral TabletPSN211ef2da-2868-4a77-8055-1cb2cd78e24b40
403879imatinib mesylate 400 MG Oral TabletPSN211ef2da-2868-4a77-8055-1cb2cd78e24b40
404588imatinib 100 MG Oral Tablet [Gleevec]SBD211ef2da-2868-4a77-8055-1cb2cd78e24b40
404589imatinib 400 MG Oral Tablet [Gleevec]SBD211ef2da-2868-4a77-8055-1cb2cd78e24b40
403878imatinib 100 MG Oral TabletSCD211ef2da-2868-4a77-8055-1cb2cd78e24b40
403879imatinib 400 MG Oral TabletSCD211ef2da-2868-4a77-8055-1cb2cd78e24b40
404588Gleevec 100 MG Oral TabletSY211ef2da-2868-4a77-8055-1cb2cd78e24b40
404589Gleevec 400 MG Oral TabletSY211ef2da-2868-4a77-8055-1cb2cd78e24b40
403878imatinib (as imatinib mesylate) 100 MG Oral TabletSY211ef2da-2868-4a77-8055-1cb2cd78e24b40
403879imatinib (as imatinib mesylate) 400 MG Oral TabletSY211ef2da-2868-4a77-8055-1cb2cd78e24b40

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0078-0401-340007804013490 TABLET in 1 BOTTLE (0078-0401-34) 90 tablet2001-05-150000-00-00NoNoCurrent